{"tool_name":"synpred","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"synpred","home":"http://www.moreiralab.com/resources/synpred/","license":"GPL-3.0","summary":"SynPred (Data-Driven Molecular Design) is a tool for prediction of drug combination effects in cancer using full-agreement synergy metrics and deep learning. SynPred, which leverages state-of-the-art AI advances, specifically designed ensembles of ML and DL algorithms to link in an interdisciplinary approach omics and biophysical traits to predict anticancer drug synergy.","addition_date":"2021-12-06T14:10:58.898356Z","last_update_date":"2022-01-06T17:12:59.325595Z","tool_type":["Web application"]},"bioschemas":{"name":"SynPred","home":"https://bio.tools/synpred","license":"GPL-3.0","summary":"SynPred (Data-Driven Molecular Design) is a tool for prediction of drug combination effects in cancer using full-agreement synergy metrics and deep learning. SynPred, which leverages state-of-the-art AI advances, specifically designed ensembles of ML and DL algorithms to link in an interdisciplinary approach omics and biophysical traits to predict anticancer drug synergy.","tool_type":"sc:SoftwareApplication"}}}